3
Announcements
Trials
Browse
Landscape
Sponsor
Cancer Type
Gastrointestinal
27
Thoracic
21
Other solid neoplasm
13
Head & Neck
4
Tumor-Agnostic
3
Lymphoid
3
Dermatologic
3
Genitourinary
2
Other hematologic neoplasm
1
Breast
1
Interventions
fludarabine
33
Specimen Handling
32
Azacitidine
30
venetoclax
29
Cyclophosphamide
29
Biopsy
25
fludarabine phosphate
23
Whole-Body Irradiation
19
Cytarabine
19
ruxolitinib
18
Mycophenolic Acid
18
Busulfan
18
Tacrolimus
16
asciminib
15
Melphalan
14
Injections
14
Decitabine
14
X-Rays
12
Stem Cell Transplantation
12
Granulocyte Colony-Stimulating Factor
12
decitabine and cedazuridine drug combination
11
Magnetic Resonance Spectroscopy
11
Cyclosporine
11
Sirolimus
10
Peripheral Blood Stem Cell Transplantation
10
Thiotepa
9
Filgrastim
9
nilotinib
7
Methotrexate
7
Imatinib Mesylate
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
tislelizumab
×
Myeloid
×
90 days
×
Clear all
No trials found.